I  U  P  A  C






News & Notices

Organizations & People

Standing Committees

Divisions

Projects

Reports

Publications
..CI
..PAC
..Macro. Symp.
..Books
..Solubility Data

Symposia

AMP

Links of Interest

Search the Site

Home Page

 

 

Analogue-based Drug Discovery

Edited by Janos Fischer and C. Robin Ganellin

Wiley-VCH, 2006 [ISBN 3-527-31257-9]


The first authoritative overview of past and current strategies for successful drug development by molecular modification of known leads. This unique resource spans the important drug classes in most major therapeutic fields.

Analogue-based drug discovery is discussed among others, for beta blockers, ACE inhibitors, steroids, opiates, stigmines, proton pump inhibitors, platinum anti-cancer compounds and anti-infective quinolones.

Statistically, every second drug is an analogue, and their market value amounts to two thirds of all drugs. Analogues are the most successful way of inventing a new drug and they provide the required improvements in drug therapy.

Case studies, by the respective inventors on selected commercially successful drug analogues provide prime advice for new drug development projects based on analogue modification.

The book includes a table of the most successful drug analogues as based on the IMS ranking and compares them in terms of chemical structure, mode of action, launch year and patent priority.

> online book [doi:10.1002/3527608001]

Contents

Introduction

GENERAL ASPECTS OF ANALOGUE-BASED DRUG DISCOVERY
- Analogues as Means of Discovering New Drugs
- Drug Likeness and Analogue-Based Drug Discovery
- Privileged Structures and Analogue-based Drug Discovery

SELECTED EXAMPLES FROM THE ANALOGUE-BASED DRUG DISCOVERY
- Development of Anti-ulcer H2-Receptor Histamine Antagonists
- Case History Omeprazole-Esomeprazole
- Case History of Pantoprazole
- Optimizing the Clinical Pharmacologic Properties of the HMG-CoA Reductase Inhibitors
- Optimizing antihypertensive Therapy by Angiotensin Receptor Blockers
- Optimizing Antihypertensive Therapy by Angiotensin-Converting Entyme Inhibitors
- Case Study of Lacidinpine in the Research of New Calcium Antagonists
- Selective Beta-Adrenergic Receptor blocking Agents
- Case Study: "Esmolol Stat"
- Development of Organic Nitrates for Coronary Heart Disease
- Development of Opioid Receptor Ligands
- Stigmines
- Structural Analogues of Clozapine
- Quinolone antibiotics - The Development of Moxifloxiacin
- The Development of Bisphosphonates as Drugs
- Cisplatin and Its Analogues for Cancer Chemotherapy
- The History of Drospirenone
- Histamine H1 Blockers; from Relative Failures to Blockbusters within Series of Anaologues
- Corticosteroids: form Natural Products to Useful Analogues

TABLE OF ANALOGUES
(classified according to chemical analogy, mode of action, therapeutic area and patent priority)

Approx 600 pages. Hardcover

> Ordering Information @ Wiley-VCH


> Corresponding IUPAC project

<book announcement published in Chem. Int. Nov-Dec 2005>

 


Page last modified 18 October 2006.
Copyright © 2000-2006 International Union of Pure and Applied Chemistry.

Questions or comments about IUPAC
please contact the Secretariat.
Questions regarding the website
please contact Web Help.